Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arenas

Showing results (371-380 of 378) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 378 results.
Journal of Viral Hepatitis|December 16, 2016
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infectionC Perelló, J A Carrión, B Ruiz-Antorán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, et al.
Science Translational Medicine|October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatmentIrene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Nature Cell Biology|April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Cancer Research|April 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient StratificationBenedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, et al.
Science Immunology|April 17, 2026
Divergent granulopoiesis at extramedullary sites safeguards antibacterial host defenseCarlos Silvestre-Roig, Raphael Chevre, Merieme Farjia, et al.
Oncogene|December 20, 2016
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibitionF Mateo, E J Arenas, H Aguilar, et al.
Pageof 38

Showing results (371-380 of 378) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 378 results.
Journal of Viral Hepatitis|December 16, 2016
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infectionC Perelló, J A Carrión, B Ruiz-Antorán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, et al.
Science Translational Medicine|October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatmentIrene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Nature Cell Biology|April 21, 2018
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Nature Cell Biology|January 24, 2018
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER<sup>+</sup> breast cancerSylwia Gawrzak, Lorenzo Rinaldi, Sara Gregorio, et al.
Cancer Research|April 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient StratificationBenedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, et al.
Science Immunology|April 17, 2026
Divergent granulopoiesis at extramedullary sites safeguards antibacterial host defenseCarlos Silvestre-Roig, Raphael Chevre, Merieme Farjia, et al.
Oncogene|December 20, 2016
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibitionF Mateo, E J Arenas, H Aguilar, et al.
Pageof 38